Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes (T2D): Outcomes by Body Mass Index (BMI)

被引：0
|
作者：
Shatskov, Alla
Rezvani, Geoffrey
Mansfield, Traci
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1141-P
引用
收藏
页码：A299 / A299
页数：1
相关论文
共 50 条
  • [41] Body Composition Methods in Adults with Type 2 Diabetes or at Risk for T2D: a Clinical Review
    Nadia Markie Sneed
    Shannon A. Morrison
    Current Diabetes Reports, 2021, 21
  • [42] Type 2 diabetes (T2D) education for adults with ID
    Taggart, L.
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2015, 28 (01) : 58 - 58
  • [43] Effects of Dapagliflozin (DAPA), a Sodium Glucose Cotransporter 2 Inhibitor, on 24-Hour Glycemic Control in Patients with Type 2 Diabetes (T2D)
    Henry, Robert R.
    Strange, Poul
    Zhou, Rong
    Zhuplatov, Sergey B.
    Mansfield, Traci
    Klein, David
    Katz, Arie
    DIABETES, 2016, 65 : A311 - A311
  • [44] HETEROGENEITY IN RENAL COMPOSITE ENDPOINTS IN CARDIOVASCULAR OUTCOMES TRIALS IN TYPE 2 DIABETES (T2D)
    Balijepalli, C.
    Desai, K.
    Yan, K.
    Zoratti, M.
    Marshall, L.
    White, N.
    Franklin, M.
    VALUE IN HEALTH, 2019, 22 : S572 - S572
  • [45] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes with a High Baseline A1c
    Skolnik, Neil
    Bonnes, Harmony
    Katz, Arie
    Yeh, Helen
    DIABETES, 2015, 64 : A653 - A653
  • [46] TYPE 2 DIABETES PATIENTS SUBCLASSIFICATION ANALYSIS: PERSONALIZED T2D CARE OF DORZAGLIATIN
    Feng, L.
    Chen, C.
    Chen, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A87 - A87
  • [47] Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus
    Liakos, Aris
    Karagiannis, Thomas
    Bekiari, Eleni
    Boura, Panagiota
    Tsapas, Apostolos
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (02) : 61 - 67
  • [48] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
  • [49] Effect of Sotagliflozin (SOTA) on Albuminuria in Patients With Type 2 Diabetes (T2D) and CKD
    Cherney, David
    Bhatt, Deepak L.
    Szarek, Michael
    Sun, Franklin W.
    Davies, Michael J.
    Pitt, Bertram
    Steg, Philippe Gabriel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 675 - 675
  • [50] Characteristics and Burden of Macro, Micro, and Normoalbuminuria in Patients with Type 2 Diabetes (T2D)
    Blonde, Lawrence
    Wilk, Alan
    Bogdanov, Alina
    Vasey, Joe
    Kallenbach, Lee
    Durkin, Michael
    DIABETES, 2020, 69
12345